Incidence and Indicators of Suboptimal Response to Tumor Necrosis Factor Antagonist Therapy in Inflammatory Bowel Disease in Newly Industrialized Countries: Results From the EXPLORE Study: 813. (October 2019) - Al Harbi, Othman; Armuzzi, Alessandro; Chan, Webber; de Leon, Enrique Ponce; Qian, Jiaming; Shapina, Marina; Toruner, Murat; Tu, Chia‐Hung; Ye, Byong Duk; Guennec, Morgane; Sison, Cecilia; Demuth, Dirk; et al.